Dosage effect on uropathogenic <it>Escherichia coli </it>anti-adhesion activity in urine following consumption of cranberry powder standardized for proanthocyanidin content: a multicentric randomized double blind study

• Main Authors: Tenke Peter, Gausa Lluis, Matsumoto Tetsuro, Blanc-Potard Anne-Béatrice, Combescure Christophe, Botto Henry, Howell Amy B, Sotto Albert, Lavigne Jean-Philippe
• Format: Article
• Language: English
• Published: BMC 2010-04-01
• Series: BMC Infectious Diseases
• Online Access: http://www.biomedcentral.com/1471-2334/10/94

<p>Abstract</p> <p>Background</p> <p>Ingestion of cranberry (<it>Vaccinium macrocarpon </it>Ait.) has traditionally been utilized for prevention of urinary tract infections. The proanthocyanidins (PACs) in cranberry, in particular the A-type linkages have been implicated as important inhibitors of primarily P-fimbriated <it>E. coli </it>adhesion to uroepithelial cells. Additional experiments were required to investigate the persistence in urine samples over a broader time period, to determine the most effective dose per day and to determine if the urinary anti-adhesion effect following cranberry is detected within volunteers of different origins.</p> <p>Methods</p> <p>Two separate bioassays (a mannose-resistant hemagglutination assay and an original new human T24 epithelial cell-line assay) have assessed the ex-vivo urinary bacterial anti-adhesion activity on urines samples collected from 32 volunteers from Japan, Hungary, Spain and France in a randomized, double-blind versus placebo study. An <it>in vivo Caenorhabditis elegans </it>model was used to evaluate the influence of cranberry regimen on the virulence of <it>E. coli </it>strain.</p> <p>Results</p> <p>The results indicated a significant bacterial anti-adhesion activity in urine samples collected from volunteers that consumed cranberry powder compared to placebo (p < 0.001). This inhibition was clearly dose-dependent, prolonged (until 24 h with 72 mg of PAC) and increasing with the amount of PAC equivalents consumed in each cranberry powder regimen. An <it>in vivo Caenorhabditis elegans </it>model showed that cranberry acted against bacterial virulence: <it>E. coli </it>strain presented a reduced ability to kill worms after a growth in urines samples of patients who took cranberry capsules. This effect is particularly important with the regimen of 72 mg of PAC.</p> <p>Conclusions</p> <p>Administration of PAC-standardized cranberry powder at dosages containing 72 mg of PAC per day may offer some protection against bacterial adhesion and virulence in the urinary tract. This effect may offer a nyctohemeral protection.</p>